Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial

OBJECTIVE: To evaluate efficacy and safety of lacosamide (up to 12 mg/kg/day or 400 mg/day) as adjunctive treatment for uncontrolled primary generalised tonic-clonic seizures (PGTCS) in patients (≥4 years) with idiopathic generalised epilepsy (IGE). METHODS: Phase 3, double-blind, randomised, placeb...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Neurol Neurosurg Psychiatry
Главные авторы: Vossler, David G, Knake, Susanne, O'Brien, Terence J, Watanabe, Masako, Brock, Melissa, Steiniger-Brach, Björn, Williams, Paulette, Roebling, Robert
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Epilepsy
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509528/
https://ncbi.nlm.nih.gov/pubmed/32817358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2020-323524
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы